328 related articles for article (PubMed ID: 32659925)
1. Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development-A Focus on Ulcerative Colitis.
Samoilă I; Dinescu S; Costache M
Cells; 2020 Jul; 9(7):. PubMed ID: 32659925
[TBL] [Abstract][Full Text] [Related]
2. Progress on Regulation of NLRP3 Inflammasome by Chinese Medicine in Treatment of Ulcerative Colitis.
Sun HX; Zhu Y
Chin J Integr Med; 2023 Aug; 29(8):750-760. PubMed ID: 37148482
[TBL] [Abstract][Full Text] [Related]
3. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
4. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
[TBL] [Abstract][Full Text] [Related]
5. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation.
Shao BZ; Wang SL; Pan P; Yao J; Wu K; Li ZS; Bai Y; Linghu EQ
Inflammation; 2019 Aug; 42(4):1147-1159. PubMed ID: 30937839
[TBL] [Abstract][Full Text] [Related]
6. Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
Lazaridis LD; Pistiki A; Giamarellos-Bourboulis EJ; Georgitsi M; Damoraki G; Polymeros D; Dimitriadis GD; Triantafyllou K
Dig Dis Sci; 2017 Sep; 62(9):2348-2356. PubMed ID: 28523573
[TBL] [Abstract][Full Text] [Related]
7. [NLRP3 inflammasome as causative and protecting factor in pathogenesis of inflammatory bowel diseases].
Świerczyński M; Fichna J
Postepy Biochem; 2021 Mar; 67(1):44-53. PubMed ID: 34378904
[TBL] [Abstract][Full Text] [Related]
8. Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health.
Ranson N; Kunde D; Eri R
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29120406
[TBL] [Abstract][Full Text] [Related]
9. Heat shock transcription factor 2 reduces the secretion of IL-1β by inhibiting NLRP3 inflammasome activation in ulcerative colitis.
Zhang F; Zhao W; Zhou J; Wang W; Luo J; Feng Y; Wu J; Li M; Wang K; Niu J; Miao Y
Gene; 2021 Feb; 768():145299. PubMed ID: 33181254
[TBL] [Abstract][Full Text] [Related]
10. CXCL8 chemokine in ulcerative colitis.
Zhu Y; Yang S; Zhao N; Liu C; Zhang F; Guo Y; Liu H
Biomed Pharmacother; 2021 Jun; 138():111427. PubMed ID: 33706134
[TBL] [Abstract][Full Text] [Related]
11. TM9SF4 Is a Crucial Regulator of Inflammation and ER Stress in Inflammatory Bowel Disease.
Xie M; Mak JWY; Yu H; Cheng CTY; Chan HCH; Chan TT; Lau LHS; Wong MTL; Ko WH; Jiang L; Yao X
Cell Mol Gastroenterol Hepatol; 2022; 14(2):245-270. PubMed ID: 35398597
[TBL] [Abstract][Full Text] [Related]
12. [Inflammatory bowel diseases and inflammasome].
Kim JM
Korean J Gastroenterol; 2011 Dec; 58(6):300-10. PubMed ID: 22198227
[TBL] [Abstract][Full Text] [Related]
13. Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagy in colonic epithelial cells.
Yue C; Yang X; Li J; Chen X; Zhao X; Chen Y; Wen Y
Biochem Biophys Res Commun; 2017 Aug; 490(2):541-551. PubMed ID: 28629999
[TBL] [Abstract][Full Text] [Related]
14. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors.
Bauer C; Duewell P; Lehr HA; Endres S; Schnurr M
Dig Dis; 2012; 30 Suppl 1():82-90. PubMed ID: 23075874
[TBL] [Abstract][Full Text] [Related]
15. Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer?
Ngui IQH; Perera AP; Eri R
Molecules; 2020 May; 25(10):. PubMed ID: 32456012
[TBL] [Abstract][Full Text] [Related]
16. 1,25(OH)
Cao R; Ma Y; Li S; Shen D; Yang S; Wang X; Cao Y; Wang Z; Wei Y; Li S; Liu G; Zhang H; Wang Y; Ma Y
J Leukoc Biol; 2020 Jul; 108(1):283-295. PubMed ID: 32237257
[TBL] [Abstract][Full Text] [Related]
17. Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential.
Xu Q; Sun W; Zhang J; Mei Y; Bao J; Hou S; Zhou X; Mao L
Front Immunol; 2022; 13():963291. PubMed ID: 36090968
[TBL] [Abstract][Full Text] [Related]
18. NLRP3: A Promising Therapeutic Target for Inflammatory Bowel Disease.
Zhang J; Zeng S; Wang P; Chen Y; Zeng C
Curr Drug Targets; 2023; 24(14):1106-1116. PubMed ID: 37946354
[TBL] [Abstract][Full Text] [Related]
19. Autophagy Induction Ameliorates Inflammatory Responses in Intestinal Ischemia-Reperfusion Through Inhibiting NLRP3 Inflammasome Activation.
Wang Z; Li Z; Feng D; Zu G; Li Y; Zhao Y; Wang G; Ning S; Zhu J; Zhang F; Yao J; Tian X
Shock; 2019 Sep; 52(3):387-395. PubMed ID: 30216227
[TBL] [Abstract][Full Text] [Related]
20. The serotonin reuptake transporter is reduced in the epithelium of active Crohn's disease and ulcerative colitis.
Jørandli JW; Thorsvik S; Skovdahl HK; Kornfeld B; Sæterstad S; Gustafsson BI; Sandvik AK; van Beelen Granlund A
Am J Physiol Gastrointest Liver Physiol; 2020 Dec; 319(6):G761-G768. PubMed ID: 32967429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
